Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Wed Apr 02 18:15:34 GMT 2025
by
admin
on
Wed Apr 02 18:15:34 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | AUTOLOGOUS HUMAN |
| Source Materials State | LIVE GENETICALLY MODIFIED |
| Source Materials Parent | |
| Part | blood |
| Fraction Name | t cells, monocytes, nk cells, or b cells |
| Record UNII |
NKC6YR89C7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000056442
Created by
admin on Wed Apr 02 18:15:35 GMT 2025 , Edited by admin on Wed Apr 02 18:15:35 GMT 2025
|
PRIMARY | |||
|
12777
Created by
admin on Wed Apr 02 18:15:35 GMT 2025 , Edited by admin on Wed Apr 02 18:15:35 GMT 2025
|
PRIMARY | |||
|
NKC6YR89C7
Created by
admin on Wed Apr 02 18:15:35 GMT 2025 , Edited by admin on Wed Apr 02 18:15:35 GMT 2025
|
PRIMARY | |||
|
C206977
Created by
admin on Wed Apr 02 18:15:35 GMT 2025 , Edited by admin on Wed Apr 02 18:15:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->VACCINE ANTIGEN |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| Cell Squeeze Process | GENE ADDITION | mbIL-2 mRNA (mRNA for the membrane bound human IL-2) | L2S9NE5V6V | ||
| Cell Squeeze Process | GENE ADDITION | HPV16 E6 mRNA | 6N4MV78HNX | ||
| Cell Squeeze Process | GENE ADDITION | CD86 mRNA (mRNA for the human CD86 protein) | Z9VX6HD5TY | ||
| Cell Squeeze Process | GENE ADDITION | mbIL-12 mRNA (mRNA for the membrane bound human IL-12) | EA585K5UYN | ||
| Cell Squeeze Process | GENE ADDITION | HPV16 E7 mRNA | E688CZ7WZD |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| VECTOR EXPRESSED PROTEIN | HUMAN PAPILLOMAVIRUS TYPE 16 PROTEIN E7 | NQK5L7WE48 | ||||
| VECTOR EXPRESSED PROTEIN | PROTEIN E6 (HUMAN PAPILLOMAVIRUS TYPE 16) | 9Z6229JXZ6 | ||||
| VECTOR EXPRESSED PROTEIN | T-LYMPHOCYTE ACTIVATION ANTIGEN CD86 | 3S33IH52EL | ||||
| VECTOR EXPRESSED PROTEIN | mbIL-2 mRNA encoded fusion protein of the transmembrane portion of the transferrin receptor and the cytokine IL-2 linked by a glycine (G) serine (S) motif | D7G89L3KE3 | ||||
| VECTOR EXPRESSED PROTEIN | mbIL-12 mRNA encoded fusion protein of the transmembrane portion of the transferrin receptor and the cytokine IL-12 linked by a glycine (G) serine (S) motif | J3AW84Q5DC |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
|
|||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
|
|||
| ANTIGEN EXPRESSED | CHEMICAL |
|
|
|||
| ANTIGEN EXPRESSED | CHEMICAL |
|
|
|||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
|
|||
